<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03450902</url>
  </required_header>
  <id_info>
    <org_study_id>Z161100000516156</org_study_id>
    <nct_id>NCT03450902</nct_id>
  </id_info>
  <brief_title>Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence</brief_title>
  <official_title>Combination Therapy With Chinese Herbal Formula, Yiqi Suoquan Granule, and Acupuncture for Female Mixed Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether combination therapy with Chinese herbal
      formula, Yiqi Suoquan granule, and acupuncture is effective in the treatment of female mixed
      urinary incontinence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This factorial, randomized, controlled trial is aimed to assess the effectiveness of
      combination therapy with Chinese herbal formula, Yiqi Suoquan granule, and acupuncture in the
      treatment of female mixed urinary incontinence (MUI). Eligible participants will be randomly
      allocated to receiving combination therapy with Yiqi Suoquan granule and acupuncture, Yiqi
      Suoquan ganule plus sham acupuncture, placebo plus acupuncture, or placebo plus sham
      acupuncture.

      To minimize the evaluation bias, the outcome assessors and statisticians will be masked to
      treatment allocation besides participants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2018</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in incontinence episode per 24 h</measure>
    <time_frame>8 week (post-treatment) and 12 week (follow-up)</time_frame>
    <description>assessed by 72 h bladder diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in ICIQ-SF questionnaire</measure>
    <time_frame>8 week (post-treatment) and 12 week (follow-up)</time_frame>
    <description>assessed by ICIQ-SF questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in I-QOL questionnaire</measure>
    <time_frame>8 week (post-treatment) and 12 week (follow-up)</time_frame>
    <description>assessed by I-QOL questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of participants with more than 50% improvement in incontinence episodes per 24h</measure>
    <time_frame>8 week (post-treatment)</time_frame>
    <description>assessed by 72 h bladder diary</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Chinese herb &amp; acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will take Yiqi Suoquan granule and receive acupuncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chinese herb &amp; sham acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will take Yiqi Suoquan granule and receive sham acupuncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo &amp; acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will take placebo granule and receive acupuncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo &amp; sham acupuncture</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will take placebo granule and receive sham acupuncture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Chinese herb &amp; acupuncture</intervention_name>
    <description>Participants will take Chinese herbal formula, Yiqi Suoquan granule, which is composed of Radix Astragali 30 g, Radix Codonopsis pilosula 10g, Radix Angelica sinensis 10g, Radix Atractylodis Macrocephalae 10g, Fructus Alpiniae Oxyphyllae 10g, Radix Lindera aggregata 6g, Rhizoma Dioscoreae 10g, pericarpium citri reticulatae 10g, Rhizoma Cimicifuga 10g, Radix Bupleuri 10g, Fructus Rubi 15g, and Semen raphani 10g and prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive acupuncture, three times a week. The selected acupoints include bilateral BL33, BL35, SP6, and ST36.</description>
    <arm_group_label>Chinese herb &amp; sham acupuncture</arm_group_label>
    <arm_group_label>Placebo &amp; acupuncture</arm_group_label>
    <arm_group_label>Placebo &amp; sham acupuncture</arm_group_label>
    <other_name>Yiqi Suoquan granule &amp; acupuncture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Chinese herb &amp; sham acupuncture</intervention_name>
    <description>Participants will take Chinese herbal formula, Yiqi Suoquan granule, which is composed of Radix Astragali 30 g, Radix Codonopsis pilosula 10g, Radix Angelica sinensis 10g, Radix Atractylodis Macrocephalae 10g, Fructus Alpiniae Oxyphyllae 10g, Radix Lindera aggregata 6g, Rhizoma Dioscoreae 10g, pericarpium citri reticulatae 10g, Rhizoma Cimicifuga 10g, Radix Bupleuri 10g, Fructus Rubi 15g, and Semen raphani 10g and prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive sham acupuncture, three times a week. The sham BL33, BL35, SP6, and ST36, which are 25 mm outward to BL33, BL35, SP6, and ST36, will be inserted with a depth of 2 to 3 mm.</description>
    <arm_group_label>Chinese herb &amp; acupuncture</arm_group_label>
    <arm_group_label>Placebo &amp; acupuncture</arm_group_label>
    <arm_group_label>Placebo &amp; sham acupuncture</arm_group_label>
    <other_name>Yiqi Suoquan granule &amp; sham acupuncture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Placebo &amp; acupuncture</intervention_name>
    <description>Participants will take Chinese herbal placebo which is prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive acupuncture, three times a week. The selected acupoints include bilateral BL33, BL35, SP6, and ST36.</description>
    <arm_group_label>Chinese herb &amp; acupuncture</arm_group_label>
    <arm_group_label>Chinese herb &amp; sham acupuncture</arm_group_label>
    <arm_group_label>Placebo &amp; sham acupuncture</arm_group_label>
    <other_name>placebo granule &amp; acupuncture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo &amp; sham acupuncture</intervention_name>
    <description>Participants will take Chinese herbal placebo which is prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive sham acupuncture, three times a week. The sham BL33, BL35, SP6, and ST36, which are 25 mm outward to BL33, BL35, SP6, and ST36, will be inserted with a depth of 2 to 3 mm.</description>
    <arm_group_label>Chinese herb &amp; acupuncture</arm_group_label>
    <arm_group_label>Chinese herb &amp; sham acupuncture</arm_group_label>
    <arm_group_label>Placebo &amp; acupuncture</arm_group_label>
    <other_name>placebo granule &amp; sham acupuncture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (1) female, leaking with urgency and with physical activity, coughing or sneezing
             (MUI) for more than 1 year; (2) recorded more than 1 incontinent episode per 24 hours
             in their bladder diary

        Exclusion Criteria:

          -  (1) with acute urinary tract infection; (2) with bladder outlet obstruction, (3) with
             neurogenic bladder (4) with interstitial cystitis, (5) with pelvic organ prolapse more
             than stage 2 (6) previous anti-incontinence surgery or a post-void residual urine
             volume more than 100 mL.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ran Pang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guang'anmen hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ran Pang, MD</last_name>
    <phone>+861088001040</phone>
    <email>pangran2002@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guang'anmen Hospital, China Academy of Chinese Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ran Pang, MD</last_name>
      <phone>+8610-88001040</phone>
      <email>pangran2002@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2018</study_first_submitted>
  <study_first_submitted_qc>February 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2018</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</investigator_affiliation>
    <investigator_full_name>Ran Pang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Urinary incontinence, Chinese herb, Acupuncture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The agreement for sharing IPD is not designed to be signed in informed consent form.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

